Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Consumer Drugs

Set Alert for Consumer Drugs

OTC Monograph Woes No Surprise To FDA Commissioner Nominee Gottlieb

Gottlieb was asked only one question about OTC drug regulation during his confirmation hearing before the Senate HELP Committee, but it covered a large part of FDA's current concerns about the OTC market.

United States Consumer Drug Safety
Advertisement

Latest From Consumer

'Slow-Growth' Global Trend Shakes Up P&G Product Strategy Start To Finish

P&G’s health care segment advanced 4% in the third quarter to $1.84bn, but sales declined for its other business units, a trend the firm sees worldwide across consumer industries. CFO Jon Moeller unveils the firm’s “irresistible superiority” product development strategy to counter slower global consumer spending.

United States Consumer

Consumer Business Reliable And Right At Home At GlaxoSmithKline

CEO Walmsley's familiarity with Glaxo's consumer health business was clear in her response to analysts' questions about the firm's future as a three-unit operation. The business marketing brands including Flonase and Excedrin is a more reliable revenue driver than the pharma business, she said.

Consumer Consumer

Consumer Health Weekly Trademark Review April 18, 2017

Class 3 (Cosmetics and Cleaning Preps) and Class 5 (Pharmaceuticals) compiled from the Official Gazette of the U.S. Patent and Trademark Office.

China India

Claritin 'Be An Outsider' Campaign Links Bayer Brand And Public Health

Bayer encourages people to get outside more, noting survey data that all US consumers on average spend 95% of their time indoors; 40% have seasonal allergies that could be helped by OTC antihistamines and allergy drugs such as Claritin. Goodwill-oriented campaign includes social media and philanthrophic donations.

Consumer Advertising, Marketing & Sales

Tylenol Delivers J&J Relief As Global 'Consumer Staples' Sales Slump

J&J says Tylenol outpaced other analgesics in the first quarter as its OTC franchise grew 1.4% on a reported basis to $1.01 bn. CFO Dominic Caruso said new consumer products will add 2 points of incremental growth to the segment in 2017.

United States Consumer

Teething Tablets, Toothpaste Recalls: Consumer Health Industry News Roundup

Standard Homeopathic recalls Hyland's teething products; ACT enters children's toothpaste market; Sensodyne toothpaste recalled.

Consumer Recalls

Reckitt Reaps ROI Reward In Geo-Targeted Symptoms App Promoting Mucinex, Delsym

RB’s spending on the WebMD-hosted Cold & Flu Tracker app generated an ROI three times greater than traditional digital marketing, says marketing executive Emma Howe. Similar campaigns are gaining momentum, with WebMD and Walgreens launching “Relief Advisor.”

Consumer Digital Health

Consumer Health Weekly Trademark Review April 4, 2017

OTC drug, personal care product and nutritional supplement trademark filings compiled from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals.

China India

FDA Should Call Last Round For OTC Hangover Indication, Cmte. Suggests

Comments from the Nonprescription Drug and the Drug Safety and Risk Management advisory committees during a joint meeting could push US FDA toward pulling the plug on hangover as a monograph indication.

Consumer Advisory Committees

Prestige Brands Stands By Nix Lice 'Kill' Claims Despite NAD Objection

Prestige Brands declines to comply with NAD recommendations to discontinue “kill” claims for its Nix Ultra lice treatment product, arguing that “eliminating” lice infestation is tantamount to “killing” the bugs. In response, NAD refers the firm's ad claims to FTC.

Consumer Dermatology

Consumer Health Weekly Trademark Review March 21, 2017

OTC drug, personal care product and nutritional supplement trademark filings compiled from Official Gazette of the U.S. Patent and Trademark Office, Class 3 – Cosmetics and Cleaning Preps; and Class 5 – Pharmaceuticals.

China India

What’s Next For Antacid/Analgesic OTCs After Negative US FDA Panel?

Nonprescription Drug and the Drug Safety and Risk Management advisory committees jointly vote 15-5 that combining antacid with aspirin, acetaminophen or other analgesic ingredients is not a combination that should be allowed under an OTC monograph.

Consumer Advisory Committees
See All
UsernamePublicRestriction

Register